Figure 1.

Figure 2.

Figure 3.

Figure 4.

Biomarkers in the primary biopsy and follow-up in the groups with atypical squamous epithelium with a patchy and a null reaction to p16
| Group | Case | Ki67 | E4 HPV | Nanog | HPV genotypes | Follow-up sample | Follow-up diagnosis | Time from primary biopsy to follow-up sample |
|---|---|---|---|---|---|---|---|---|
| p16 | 1 | 1/3 | - | 1+ | 31, 52 | biopsy | CIN1 | 2 years |
| null | 2 | 3/3 | - | - | 53 | biopsy | CIN2 | 2 years |
| 3 | 1/3 | - | - | - | biopsy | CIN3 | 4 months | |
| p16 patchy | 4 | 0 | - | - | 39 | cone | CIN1 | 8 months |
| 5 | 1/3 | - | - | - | cone | CIN1 | 6 years | |
| 6 | 3/3 | - | 1+ | 53 | cone | CIN3 | 5 years | |
| 7 | 3/3 | - | - | 52, 53, 56, 66, 73 | Cervical amputation | CIN3 | 10 months | |
| 8 | 1/3 | - | - | 44 | cone | CIN3 | 10 months |
Comparison of different biological markers between groups using Spearman correlation
| Groups | p16 | Ki67 | HPV E4 | Nanog | lrHPV tissue | hrHPV tissue | hrHPV: tissue+smear | lrHPV: tissue+smear |
|---|---|---|---|---|---|---|---|---|
| p16 null vs. p16 patchy | r = 1 p = 0.000 | r = 0.000 | r = 0.116 | r = 0.089 | r = 0.209 | r = 0.384 p = 0.025 | r = 0.274 | r = 0.285 |
| p16 patchy vs. condyloma | r = 0.000 | r = 0.535 p = 0.001 | r =0.280 | r = 0.494 p = 0.004 | r = 0.458 p = 0.007 | r = 0.000 | r=-0.186 | r = 0.494 p = 0.004 |
| p16 patchy vs. CIN1 | r = 0343 p = 0.041 | r = 0.35 p = 0.037 | r = 0.81 p = 0.000 | r = 0.532 p = 0.001 | r = 0.354 p = 0.034 | r = 0.161 | r = -0.039 | r = 0.359 p = 0.032 |
| p16 patchy vs. CIN2 | r = 1 p = 0.000 | r = 0.66 p = 0.000 | r = 0.728 p = 0.000 | r = 0.632 p = 0.000 | r = -0.193 | r = 0.45 p = 0.007 | r = 0.176 | r = -0.089 |
| p16 patchy vs. CIN3 | r = 1 p = 0.000 | r = 0.683 p = 0.000 | r = 0.280 | r = 0.575 p = 0.000 | r = -0.375 p = 0.032 | r = 0.594 p = 0.000 | r = 0.433 p = 0.012 | r = -0.433 p = 0.012 |
| p16 null vs. condyloma | r = 1 | r = 0.617 p = 0.004 | r = 0.369 | r = 0.664 p = 0.001 | r = 0.704 p = 0.001 | r = 0.464 p = 0.039 | r = 0.066 | r = 0.818 p = 0.000 |
| p16 null vs. CIN1 | r = 0.963 p = 0.000 | r = 0.394 | r = 0.84 p = 0.000 | r = 0.691 p = 0.000 | r = 0.568 p = 0.005 | r = 0.569 p = 0.005 | r = 0.233 | r = 0.652 p = 0.001 |
| p16 null vs. CIN2 | r = 1 | r = 0.735 p = 0.000 | r = 0.756 p = 0.000 | r = 0.728 p = 0.000 | r = 0.000 | r = 0.832 p = 0.000 | r = 0.455 p = 0.034 | r = 0.204 |
| p16 null vs. CIN3 | r = 1 | r = 0.783 p = 0.000 | r = 0.369 | r = 0.665 p = 0.001 | r = -0.302 | r = 1 | r = 0.739 p = 0.000 | r = -0.302 |
| Atypia (p16 patchy and null) vs. CIN2 | r = 0.811 p = 0.000 | r = 0.607 p = 0.000 | r = 0.751 p = 0.000 | r = 0.598 p = 0.000 | r = -0.125 | r = 0.521 p = 0.000 | r = 0.231 | r = -0.007 |
Immunohistochemical reactions to various biological markers and human papillomavirus (HPV) genotyping in tissue biopsy and previous cervical smear, where available, by study group
| Group | p16 | N | Ki67 | N | E4 HPV | N | Nanog | N | HPV genotyping | N tissue | N smear |
|---|---|---|---|---|---|---|---|---|---|---|---|
| p16 null N = 11 | Null | 11 | 0 | 5 | Neg. | 11 | Neg. | 7 | Neg | 9 | 3 |
| Patchy | 0 | 1/3 | 4 | Pos. | 0 | 1 | 4 | lrHPV only | 2 | 1 | |
| En Block | 0 | 2/3 | 0 | 2 | 0 | hrHPV | 0 | 3 | |||
| 3/3 | 2 | 3 | 0 | ||||||||
| p16 patchy N = 24 | Null | 0 | 0 | 12 | Neg. | 23 | Neg. | 13 | Neg | 10 | 2 |
| Patchy | 24 | 1/3 | 5 | Pos. | 1 | 1 | 11 | lrHPV only | 6 | 2 | |
| En Block | 0 | 2/3 | 3 | 2 | 0 | hrHPV | 8 | 12 | |||
| 3/3 | 4 | 3 | 0 | ||||||||
| Condyloma N = 9 | Null | 0 | 0 | 0 | Neg. | 7 | Neg. | 0 | Neg | 0 | 1 |
| Patchy | 9 | 1/3 | 2 | Pos. | 2 | 1 | 9 | lrHPV only | 6 | 2 | |
| En Block | 0 | 2/3 | 1 | 2 | 0 | hrHPV | 3 | 1 | |||
| 3/3 | 6 | 3 | 0 | ||||||||
| CIN1 N = 12 | Null | 0 | 0 | 2 | Neg. | 2 | Neg. | 0 | Neg | 0 | 0 |
| Patchy | 10 | 1/3 | 2 | Pos. | 10 | 1 | 12 | lrHPV only | 6 | 1 | |
| En Block | 2 | 2/3 | 4 | 2 | 0 | hrHPV | 6 | 3 | |||
| 3/3 | 4 | 3 | 0 | ||||||||
| CIN2 N = 11 | Null | 0 | 0 | 0 | Neg. | 3 | Neg. | 0 | Neg | 1 | 0 |
| Patchy | 0 | 1/3 | 0 | Pos. | 8 | 1 | 7 | lrHPV only | 2 | 0 | |
| En Block | 11 | 2/3 | 2 | 2 | 4 | hrHPV | 8 | 3 | |||
| 3/3 | 9 | 3 | 0 | ||||||||
| CIN3 N = 9 | Null | 0 | 0 | 0 | Neg. | 7 | Neg. | 1 | Neg | 0 | 0 |
| Patchy | 0 | 1/3 | 0 | Pos. | 2 | 1 | 3 | lrHPV only | 0 | 0 | |
| En Block | 9 | 2/3 | 0 | 2 | 3 | hrHPV | 9 | 4 | |||
| 3/3 | 9 | 3 | 2 |
j_raon-2025-0038_Utab_001
| 1 | |
| 0,9 | |
| 0,8 | |
| 0,7 | |
| 0,6 | |
| 0,5 | |
| 0,4 | |
| 0,3 | |
| 0,2 | |
| 0,1 | |
| 0 | |
| -0,1 | |
| -0,2 | |
| -0,3 | |
| -0,4 | |
| -0,5 | |
| -0,6 | |
| -0,7 | |
| -0,8 | |
| -0,9 | |
| -1 |
Follow-up histology, cytology, human papillomavirus (HPV) result by study groups (p16 null and p16 patchy)
| Group | Follow up histo | N | Follow up cyto | N | Follow up HPV | N |
|---|---|---|---|---|---|---|
| p16 null (11 cases, 9 biopsies) | Neg | 0 | Neg | 5 | Neg | 5 |
| CIN1 | 1 | ASC-US | 4 | Pos | 3 | |
| CIN2 | 1 | LSIL | 0 | |||
| CIN3 | 1 | HSIL | 0 | |||
| p16 patchy (24 cases, 17 biopsies) | Neg | 0 | Neg | 5 | Neg | 4 |
| CIN1 | 2 | ASC-US | 6 | Pos | 5 | |
| CIN2 | 0 | LSIL | 4 | |||
| CIN3 | 3 | HSIL | 2 |